Essa Pharma is facing a call to wind down operations. Soleus Capital Management, one of the company’s largest shareholders, put the proposal to Essa’s board of directors after concluding that the best ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

"I've been working international fugitives with the FBI about 26 years… we've arrested a lot of bad guys," says FBI Special Agent Phil Torsney. "This is a once-in-a-lifetime case…and it was certainly ...

Essa Pharma’s sole clinical-stage candidate was on track to fall short against Xtandi in a phase 2 prostate cancer trial, leading the biotech to terminate the study, abandon the candidate and “review ...

Gary S. Olson, President and CEO, commented: "In our fiscal second quarter 2025, the Company continued to generate strong, positive operational results as ESSA progressed toward the anticipated ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...

In December 2015, Congress passed the Every Student Succeeds Act (ESSA) amid strong bipartisan support. The House passed the bill by 359–64, and seven days later the Senate passed the bill 85–12; ...

Review quarterly and annual revenue, net income, and cash flow for PT Essa Industries Indonesia Tbk (ESSA:XIDX) stock through the last fiscal year.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.